Table 2 Baseline of patients with differential LDL-C levels
Factor | LDL-low n = 21 | LDL-normal n = 29 | LDL-high n = 11 | P † |
|---|---|---|---|---|
Sex | ||||
Male | 16 (76.2) | 21 (72.4) | 6 (54.5) | 1.000/0.451 |
Female | 5 (23.8) | 8 (27.6) | 5 (45.5) | |
Age | ||||
< 60 yr | 5 (23.8) | 11 (37.9) | 4 (36.4) | 0.365/1.000 |
≥ 60 yr | 16 (76.2) | 18 (62.1) | 7 (63.6) | |
Tumor location | ||||
Upper 1/3 | 4 (19.0) | 4 (13.8) | 1 (9.1) | 0.632/0.702 |
Middle 1/3 | 5 (23.8) | 11 (37.9) | 6 (54.5) | |
Lower 1/3 | 12 (57.1) | 14 (48.3) | 4 (36.4) | |
Tumor size, cm | ||||
< 3 cm | 5 (23.8) | 13 (44.8) | 3 (27.3) | 0.149/0.473 |
≥ 3 cm | 16 (76.2) | 16 (55.2) | 8 (72.7) | |
Histologic differentiation | ||||
Well | 2 (9.5) | 2 (6.9) | 0 | 1.000/0.855 |
Moderate | 9 (42.9) | 13 (44.8) | 4 (36.4) | |
Poor | 10 (47.6) | 14 (48.3) | 7 (63.6) | |
T | ||||
T1 | 3 (14.3) | 8 (27.6) | 2 (18.2) | 0.205/0.622 |
T2 | 8 (38.1) | 7 (24.1) | 1 (9.1) | |
T3 | 9 (42.9) | 8 (27.6) | 5 (45.5) | |
T4 | 1 (4.8) | 6 (20.7) | 3 (27.3) | |
N | ||||
Negative | 9 (42.9) | 14 (48.3) | 4 (36.4) | 0.778/0.723 |
Positive | 12 (57.1) | 15 (51.7) | 7 (63.6) | |
M | ||||
Negative | 21 (100.0) | 29 (100.0) | 11 (100.0) | - |
Positive | 0 | 0 | 0 | |
pStage | ||||
I | 6 (28.6) | 11 (37.9) | 2 (18.2) | 0.770/0.459 |
II | 10 (47.6) | 10 (34.5) | 4 (36.4) | |
III | 5 (23.8) | 8 (27.6) | 5 (45.5) |